NCT05224245 - ACURATE Prime XL Human Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

June 16, 2022

Study Completion Date

May 24, 2023

Conditions

Aortic Stenosis

Interventions

DEVICE

ACURATE Prime XL Transfemoral Aortic Valve System

ACURATE Prime™ Transfemoral Aortic Valve system: Support frame made of nitinol, supra-annular processed tri-leaflet porcine pericardial valve and an outer skirt to limit paravalvular regurgitation (manufactured by Boston Scientific Corporation, Marlborough, MA, USA).

Trial Locations (3)

2050

Royal Prince Alfred Hospital, Camperdown

3168

Monash Health, Clayton

4032

The Prince Charles Hospital, Brisbane